Medication and Pharmacology Terms

A substance being studied in the treatment of certain types of head and neck cancer.

A drug used to treat multiple myeloma.

The mushroom compound is a prodrug: what reaches the brain is psilocin, released once the body strips a phosphate group away.

An older spelling that persists in drug indexes and research listings, kept alive by cataloging rather than by any difference in chemistry.

A drug class named for what it does to alertness, familiar from coffee at one end and controlled prescriptions at the other.

A substance being studied in the treatment of cancer, including certain types of lung, pancreas, and brain cancer.

A substance being studied in the treatment of cancer.

A drug used to treat pain caused by bone cancer and other cancers that have spread to the bones.

A substance being studied in the treatment of cancer and certain other diseases, such as rheumatoid arthritis.

A drug that contains a radioactive substance and is used to diagnose or treat disease, including cancer.

A radiopharmaceutical is a medication containing a radioactive component, used to produce diagnostic images or deliver targeted radiation treatment.

The use of a drug that makes tumor cells more sensitive to radiation therapy.

A drug that makes tumor cells more sensitive to radiation therapy.

Raloxifene is a medication used to prevent and treat osteoporosis and to lower breast cancer risk in certain postmenopausal women.

A drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of the disease or who have osteoporosis.

An anticancer drug that stops tumor cells from growing by blocking the ability of cells to make DNA.

An approved antibody that starves tumors of new blood vessels by occupying the receptor rather than the growth signal itself.

A substance being studied in the treatment of cancer.

Named for the island where the soil bacterium was dug up, and the enzyme it blocks was later named after the drug.

Rapamycin, now known chiefly as sirolimus, suppresses immune activity by blocking a cell signaling pathway that lymphocytes and other cells need to divide.